Clover Health Investments, Corp. (NASDAQ:CLOV – Get Free Report) gapped up before the market opened on Wednesday . The stock had previously closed at $1.01, but opened at $1.04. Clover Health Investments shares last traded at $1.04, with a volume of 1,158,868 shares changing hands.
Analyst Ratings Changes
Separately, Citigroup upped their price target on Clover Health Investments from $1.00 to $1.50 and gave the stock a “neutral” rating in a research report on Friday, August 11th.
Read Our Latest Research Report on CLOV
Clover Health Investments Stock Performance
Institutional Trading of Clover Health Investments
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Legal & General Group Plc grew its position in shares of Clover Health Investments by 49.4% during the third quarter. Legal & General Group Plc now owns 270,420 shares of the company’s stock valued at $292,000 after purchasing an additional 89,373 shares in the last quarter. AQR Capital Management LLC increased its stake in Clover Health Investments by 73.5% in the 3rd quarter. AQR Capital Management LLC now owns 788,412 shares of the company’s stock worth $851,000 after acquiring an additional 333,868 shares during the last quarter. Qube Research & Technologies Ltd raised its holdings in shares of Clover Health Investments by 10.7% during the 3rd quarter. Qube Research & Technologies Ltd now owns 1,354,341 shares of the company’s stock worth $1,463,000 after acquiring an additional 131,242 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. boosted its position in shares of Clover Health Investments by 2.6% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 813,695 shares of the company’s stock valued at $879,000 after acquiring an additional 20,813 shares during the last quarter. Finally, Northern Trust Corp grew its holdings in shares of Clover Health Investments by 9.2% in the third quarter. Northern Trust Corp now owns 793,830 shares of the company’s stock valued at $857,000 after purchasing an additional 66,590 shares in the last quarter. Institutional investors own 19.95% of the company’s stock.
Clover Health Investments Company Profile
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses.
Recommended Stories
- Five stocks we like better than Clover Health Investments
- The How and Why of Investing in Biotech Stocks
- Williams-Sonoma is a steal for buy-and-hold investors
- How to Invest in Blue Chip Stocks
- A closer look at Warren Buffett’s latest surprise purchase
- Roth IRA Calculator: Calculate Your Potential Returns
- GE stock surges to six-year high: What’s behind the move?
Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.